Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Luxendo
company
About
Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.
- Heidelberg,Baden-Wurttemberg,Germany
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €8M
- Industries
- Bioinformatics,Biotechnology,Manufacturing
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- LUXENDO GmbH
Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniques of widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€14M
Luxendo has raised a total of
€14M
in funding over 2 rounds. Their latest funding was raised on
Jan 12, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 12, 2017 | Series A | €8M | 3 |
EMBL Ventures
EMBLEM Technology Transfer
LSP BioVentures
|
— | Detail |
| Oct 14, 2015 | Series A | €6M | 2 |
EMBL Ventures
Life Sciences Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
5
4
Luxendo is funded by 4 investors.
EMBL Ventures
and EMBLEM Technology Transfer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
EMBL Ventures
|
Yes | Series A |
|
EMBLEM Technology Transfer
|
Yes | Series A |
|
LSP BioVentures
|
Yes | Series A |
|
Life Sciences Partners
|
Yes | Series A |
Employee Profiles
Number of Employee Profiles
1
Luxendo has 1 current employee profiles, including
Executive Joachim Rothe
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
